Institutional Ownership Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT). We have compiled data on the 159 institutions that hold shares in the stock, with a total of 67.1 Million shares, which have been reported (via 13F filing form) to have a value of $916 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Caption Management, LLC
Oklahoma City, OK |
Aug 14, 2025 Q2 2025 |
119,566
shares
|
$1.7 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Panagora Asset Management Inc
Boston, MA |
Aug 13, 2025 Q2 2025 |
116,099
shares
|
$1.65 Million
0.01% of portfolio
|
Q1 2025
Added 5.02%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
113,730
shares
|
$1.61 Million
0.0% of portfolio
|
Q2 2025
Reduced 41.65%
|
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
112,400
shares
|
$1.59 Million
0.0% of portfolio
|
Q1 2025
Added 12.4%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
99,764
shares
|
$1.42 Million
0.07% of portfolio
|
Q2 2025
New holding
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
96,280
shares
|
$1.37 Million
0.0% of portfolio
|
Q2 2025
Added 11.01%
|
|
|
Hrt Financial LP
New York, NY |
Aug 14, 2025 Q2 2025 |
95,613
shares
|
$1.36 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Aug 14, 2025 Q2 2025 |
94,075
shares
|
$1.33 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.19%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
83,709
shares
|
$1.19 Million
0.0% of portfolio
|
Q2 2025
Reduced 93.82%
|
|
|
Simplify Asset Management Inc.
New York, NY |
Aug 07, 2025 Q2 2025 |
79,472
shares
|
$1.13 Million
0.04% of portfolio
|
Q2 2025
Reduced 9.85%
|
|
|
State Of Wisconsin Investment Board
Madison, WI |
Aug 14, 2025 Q2 2025 |
78,647
shares
|
$1.12 Million
0.0% of portfolio
|
Q2 2025
Added 258.74%
|
|
|
Dynamic Technology Lab Private LTD
Singapore, U0 |
May 16, 2025 Q1 2025 |
73,310
shares
|
$1.04 Million
0.06% of portfolio
|
Q1 2025
Added 127.83%
|
|
|
Man Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
72,682
shares
|
$1.03 Million
0.0% of portfolio
|
Q2 2025
Added 400.94%
|
|
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
Aug 13, 2025 Q2 2025 |
71,515
shares
|
$1.01 Million
0.0% of portfolio
|
Q3 2024
Reduced 74.71%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
69,962
shares
|
$992,760
0.0% of portfolio
|
Q2 2025
Added 207.97%
|
|
|
Woodstock Corp
|
Jul 09, 2025 Q2 2025 |
68,465
shares
|
$971,518
0.06% of portfolio
|
Q2 2025
Reduced 4.22%
|
|
|
American Century Companies Inc
Kansas City, MO |
Aug 12, 2025 Q2 2025 |
67,612
shares
|
$959,414
0.0% of portfolio
|
Q2 2025
Added 57.75%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
65,568
shares
|
$930,409
0.0% of portfolio
|
Q2 2025
Added 8.56%
|
|
|
Susquehanna Portfolio Strategies, LLC
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
61,194
shares
|
$868,342
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
58,590
shares
|
$831,392
0.0% of portfolio
|
Q2 2025
Added 15.13%
|
|
|
Erste Asset Management Gmb H
Vienna, C4 |
Aug 14, 2025 Q2 2025 |
50,000
shares
|
$709,500
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Squarepoint Ops LLC
New York, NY |
Aug 27, 2025 Q2 2025 |
48,422
shares
|
$687,108
0.0% of portfolio
|
Q2 2025
Added 153.89%
|
|
|
Entry Point Capital, LLC
New York, NY |
Aug 11, 2025 Q2 2025 |
45,225
shares
|
$641,742
0.23% of portfolio
|
Q2 2025
Added 31.76%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
41,152
shares
|
$583,946
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Met Life Investment Management, LLC
Whippany, NJ |
Aug 13, 2025 Q2 2025 |
39,718
shares
|
$563,598
0.0% of portfolio
|
Q1 2025
Reduced 1.94%
|